ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Dementia
Cognitive Dysfunction
Mental Disorders
Psychomotor Agitation
Brain Diseases
Neurodegenerative Diseases

Alzheimer's Disease trials near Budapest, Budapest, HUN:

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: KarXT

Phase 3

Karuna Therapeutics
Karuna Therapeutics

Budapest, Hungary and 189 other locations

female subjects who are aged 55 to 90 years and have mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis rela...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: Placebo
Drug: KarXT

Phase 3

Karuna Therapeutics
Karuna Therapeutics

Budapest, Hungary and 152 other locations

psychosis associated with Alzheimer's Disease....

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: KarXT

Phase 3

Karuna Therapeutics
Karuna Therapeutics

Budapest, Hungary and 208 other locations

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...

Active, not recruiting
Early Alzheimer's Disease
Drug: Placebo (semaglutide)
Drug: Semagludtide

Phase 3

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 341 other locations

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...

Active, not recruiting
Early Alzheimer´s Disease
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 381 other locations

hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's...

Active, not recruiting
Agitation in Patients with Dementia of the Alzheimer's Type
Drug: Placebo
Drug: AVP-786

Phase 3

Otsuka
Otsuka

Budapest, Hungary and 105 other locations

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...

Active, not recruiting
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786

Phase 3

Otsuka
Otsuka

Budapest, Hungary and 232 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems